CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Roche Holding AG is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Roche Holding AG
Grenzacherstrasse 124
Phone: +41 9732354295p:+41 9732354295 BASEL, 4002  Switzerland Ticker: ROGROG
Business Summary
Roche Holding AG (Roche) is a research-based healthcare company. The Company's operating businesses are organized into two divisions: Pharmaceuticals and Diagnostics. The Pharmaceuticals Division consists of two business segments: Roche Pharmaceuticals and Chugai. The Diagnostics Division consists of four business areas: Diabetes Care, Molecular Diagnostics, Professional Diagnostics and Tissue Diagnostics. The Company develops medicines for various disease areas, including oncology, immunology, infectious diseases, ophthalmology and neuroscience. Its pharmaceutical products include Anaprox, Avastin, Bactrim, Bondronat, CellCept, Cotellic, Dilatrend, Dormicum, Invirase, Kadcyla, Kytril (Kevatril), Lariam, MabThera, Madopar, Neupogen, Pegasys, Perjeta, Pulmozyme, Rocaltrol, Rocephin and Roferon-A. The Company offers products for researchers, including cell analysis, gene expression, genome sequencing and nucleic acid purification.

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
YesYes-YesYesYes-

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
6/30/202412/31/2023YesYes-YesYes

Industries
SIC Code Description
2834 Pharmaceutical preparations
2836 Biological products, except diagnostic substances
2835 In vitro and in vivo diagnostic substances
3826 Laboratory analytical instruments
3842 Orthopedic, prosthetic, and surgical appliances and supplies
3841 Surgical and medical instruments and apparatus
2833 Medicinal chemicals and botanical products
3845 Electromedical and electrotherapeutic apparatus
6719 Offices of holding companies, not elsewhere classified

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Non-Executive Chairman of the Board Severin A.Schwan 57 3/14/2023 1/1/2006
Chief Executive Officer, Member of the Corporate Executive Committee ThomasSchinecker 49 3/14/2023 8/1/2019
Non-Executive Independent Vice Chairman of the Board Andre S.Hoffmann 65
12 additional Officers and Directors records available in full report.

Subsidiaries
Business Name Address City State/Province Country
Roche Diagnostics Nederland B.V. Transistorstraat 41 ALMERE NL
Inflazome Ltd. The Tower, Trinity TEC Dublin, 2 Ireland
Roche Diagnostics Oy Espoo FI
30 additional Subsidiary records available in full report.

Business Names
Business Name
0QOK
0QQ6
454 Life Sciences
54 additional Business Names available in full report.

General Information
Number of Employees: 103,605 (As of 12/31/2023)
Outstanding Shares: 796,789,129 (As of 6/30/2024)
Shareholders: 1,585
Stock Exchange: SWF
Federal Tax Id: 132511923


Copyright © 2024 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Tuesday, December 3, 2024